Publications

This fact sheet provides information on the national NBS decision-making pathway, including the role of each committee in the process.

This fact sheet provides information about what NBS expansion means for families and consumers, expansion progress to date, and upcoming milestones.

This publication outlines the key findings of the national readiness assessment conducted in 2023. The aim of the readiness assessment is to understand how NBS programs operate nationally. It also looks at critical factors for achieving consistency and expanding the number of conditions screened.

This document includes information to help clinicians and pharmacists connect to the National Prescription Delivery Service.

This publication outlines the key findings from our public consultation on the expansion of newborn bloodspot screening programs.

This report gives an overview of the public consultation process that we undertook for the expansion of newborn bloodspot screening programs.

This document includes information to help developers connect to the National Prescription Delivery Service.

Tasmanian Health Service information brochure explaining how newborn bloodspot screening works in Tasmania.

South Australia Pathology brochure explaining how newborn bloodspot screening works in South Australia.

This fact sheet outlines accessing medicines through electronic prescriptions.

The Electronic Prescribing Active Script List (ASL) Privacy Framework describes the privacy, identity and consent processes that relate to release 1 of the implementation of Active Script List functionality.

This policy outlines the privacy responsibilities of non-government organisations involved in the electronic prescribing process.

This policy describes how personal information and related data contained in electronic prescriptions is collected, used and disclosed.

This report details the Summary of Privacy Impact Assessment on the Electronic Prescribing Project. Electronic Prescribing is being implemented to increase PBS compliance and efficiency, improve drug safety, and support better data collection.

The Electronic Prescriptions Security and Access Policy describes how health care provider organisations must manage the security and integrity of their software, to make sure they dispense electronic prescriptions securely.

The Form of the Electronic Prescription 2019 defines the information fields required when a PBS prescriber writes an electronic prescription.

The Electronic Prescriptions Information Technology Requirements Instrument 2019 details system requirements for participating in electronic prescribing and refers to system obligations to adhere to security, privacy and data usage policies.

The Newborn Bloodspot Screening National Policy Framework guides the national policies needed to support the ongoing success of newborn bloodspot screening in Australia.